Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Piwi-like protein 4 (PIWIL4) is an Argonaute family protein characterized by its critical role in gene silencing through the piRNA pathway[4]. It is primarily involved in repressing transposable elements and maintaining genomic integrity during spermatogenesis. The protein operates via complex formation with piRNAs, which mediate DNA methylation and histone modification, leading to transcriptional silencing of transposons and other repeated genomic sequences. Unlike some related Piwi proteins, PIWIL4 does not possess endonuclease activity. Beyond its function in the germline, PIWIL4 exerts epigenetic regulatory effects in somatic tissues: it helps enforce HIV-1 latency by recruiting chromatin modifiers (e.g., HDAC4) and instituting repressive histone marks at the viral promoter region[1]. In neural differentiation, PIWIL4 interacts with the demethylase UTX to remove repressive histone marks (H3K27me3) and promote the expression of neuronal genes[2]. In cancer biology, PIWIL4 is associated with increased cell proliferation, migration, and immune evasion, notably through the repression of MHC class II expression[3]. PIWIL4 is thus considered a promising therapeutic target in epigenetic therapy for cancer and HIV-1 latency, though modulation poses substantial safety concerns due to its involvement in essential cellular and genomic processes[1][2][3][4].
Epigenetic modification reversal: Latency-reversing agents may induce viral reactivation by interfering with PIWIL4-mediated (and HDAC4-supported) repression of HIV-1 transcription - Inhibition or modulation of PIWIL4 function may regulate cancer cell proliferation and promote apoptosis
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Piwi-like protein 4 (PIWIL4).